Literature DB >> 21150647

Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition.

Christian Braegger1, Anna Chmielewska, Tamas Decsi, Sanja Kolacek, Walter Mihatsch, Luis Moreno, Małgorzata Pieścik, John Puntis, Raanan Shamir, Hania Szajewska, Dominique Turck, Johannes van Goudoever.   

Abstract

Infant formulae are increasingly supplemented with probiotics, prebiotics, or synbiotics despite uncertainties regarding their efficacy. The present article, developed by the Committee on Nutrition of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition, systematically reviews published evidence related to the safety and health effects of the administration of formulae supplemented with probiotics and/or prebiotics compared with unsupplemented formulae. Studies in which probiotics/prebiotics were not administered during the manufacturing process, but thereafter, for example in capsules, the contents of which were supplemented to infant formula or feeds, were excluded.On the basis of this review, available scientific data suggest that the administration of currently evaluated probiotic- and/or prebiotic-supplemented formula to healthy infants does not raise safety concerns with regard to growth and adverse effects. The safety and clinical effects of 1 product should not be extrapolated to other products. At present, there is insufficient data to recommend the routine use of probiotic- and/or prebiotic-supplemented formulae. The Committee considers that the supplementation of formula with probiotics and/or prebiotics is an important field of research. There is a need in this field for well-designed and carefully conducted randomised controlled trials, with relevant inclusion/exclusion criteria and adequate sample sizes. These studies should use validated clinical outcome measures to assess the effects of probiotic and/or prebiotic supplementation of formulae. Such trials should also define the optimal doses and intake durations, as well as provide more information about the long-term safety of probiotics and/or prebiotics. Because most of the trials were company funded, independent trials, preferentially financed jointly by national/governmental/European Union bodies and other international organisations, would be desirable.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21150647     DOI: 10.1097/MPG.0b013e3181fb9e80

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  77 in total

1.  Determinants of infant formula use and relation with growth in the first 4 months.

Authors:  Aisha Betoko; Marie-Aline Charles; Régis Hankard; Anne Forhan; Mercedes Bonet; Nolwenn Regnault; Jérémie Botton; Marie-Josephe Saurel-Cubizolles; Blandine de Lauzon-Guillain
Journal:  Matern Child Nutr       Date:  2012-05-29       Impact factor: 3.092

Review 2.  Probiotics and necrotizing enterocolitis.

Authors:  Josef Neu
Journal:  Clin Perinatol       Date:  2014-09-30       Impact factor: 3.430

Review 3.  Diet and the intestinal microbiome: associations, functions, and implications for health and disease.

Authors:  Lindsey G Albenberg; Gary D Wu
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

Review 4.  The association between dietary fibre deficiency and high-income lifestyle-associated diseases: Burkitt's hypothesis revisited.

Authors:  Stephen J O'Keefe
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12

Review 5.  The Long-Term Effects of Dietary Nutrient Intakes during the First 2 Years of Life in Healthy Infants from Developed Countries: An Umbrella Review.

Authors:  Carlo Agostoni; Anat Guz-Mark; Luba Marderfeld; Gregorio P Milani; Marco Silano; Raanan Shamir
Journal:  Adv Nutr       Date:  2019-05-01       Impact factor: 8.701

6.  Microencapsulation May Preserve the Viability of Probiotic Bacteria During a Baking Process and Digestion: A Case Study with Bifidobacterium animalis Subsp. lactis in Bread.

Authors:  Adel Penhasi; Albert Reuveni; Israel Baluashvili
Journal:  Curr Microbiol       Date:  2021-01-03       Impact factor: 2.188

7.  In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics.

Authors:  Tatiana Christides; Julia Clark Ganis; Paul Anthony Sharp
Journal:  Eur J Nutr       Date:  2016-12-09       Impact factor: 5.614

Review 8.  The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota.

Authors:  Christian Milani; Sabrina Duranti; Francesca Bottacini; Eoghan Casey; Francesca Turroni; Jennifer Mahony; Clara Belzer; Susana Delgado Palacio; Silvia Arboleya Montes; Leonardo Mancabelli; Gabriele Andrea Lugli; Juan Miguel Rodriguez; Lars Bode; Willem de Vos; Miguel Gueimonde; Abelardo Margolles; Douwe van Sinderen; Marco Ventura
Journal:  Microbiol Mol Biol Rev       Date:  2017-11-08       Impact factor: 11.056

Review 9.  Microbial therapeutic interventions.

Authors:  Nicole G Grady; Elaine O Petrof; Erika C Claud
Journal:  Semin Fetal Neonatal Med       Date:  2016-04-25       Impact factor: 3.926

Review 10.  Early life microbial exposures and allergy risks: opportunities for prevention.

Authors:  Harald Renz; Chrysanthi Skevaki
Journal:  Nat Rev Immunol       Date:  2020-09-11       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.